Embolex and Diffuse interstitial lung disease - a phase IV clinical study of FDA data

Summary:

Diffuse interstitial lung disease is reported only by a few people who take Embolex.

The phase IV clinical study analyzes which people take Embolex and have Diffuse interstitial lung disease. It is created by eHealthMe based on reports of 1,146 people who have side effects while taking Embolex from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

1,146 people reported to have side effects when taking Embolex.
Among them, 2 people (0.17%) have Diffuse interstitial lung disease.


What is Embolex?

Embolex has active ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride. eHealthMe is studying from 1,148 Embolex users for its effectiveness, alternative drugs and more.

What is Diffuse interstitial lung disease?

Diffuse interstitial lung disease (group of lung diseases affecting the interstitium) is found to be associated with 876 drugs and 698 conditions by eHealthMe.

Number of Embolex and Diffuse interstitial lung disease reports submitted per year:

Could Embolex cause Diffuse interstitial lung disease?

Gender of people who have Diffuse interstitial lung disease when taking Embolex *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Diffuse interstitial lung disease when taking Embolex *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Embolex *:

  1. Nexium: 2 people, 100.00%
  2. Mirtazapine: 2 people, 100.00%
  3. Lorazepam: 2 people, 100.00%
  4. Lasix: 2 people, 100.00%
  5. Gemzar: 2 people, 100.00%
  6. Enalapril Maleate: 2 people, 100.00%

Common side effects people have besides Diffuse interstitial lung disease *:

  1. Urinary Tract Infection: 2 people, 100.00%
  2. Urinary Retention (the inability to completely or partially empty the bladder): 2 people, 100.00%
  3. Thrombocytopenia (decrease of platelets in blood): 2 people, 100.00%
  4. Orthopnea (shortness of breath (dyspnea) when lying down): 2 people, 100.00%
  5. Leukopenia (less number of white blood cells in blood): 2 people, 100.00%
  6. Interstitial Lung Disease: 2 people, 100.00%
  7. High Blood Pressure: 2 people, 100.00%
  8. Fungal Infection: 2 people, 100.00%
  9. Anaemia (lack of blood): 2 people, 100.00%
  10. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 100.00%

Common conditions people have *:

  1. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Embolex and have Diffuse interstitial lung disease?

Check whether Diffuse interstitial lung disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Diffuse interstitial lung disease and when was it recovered:

Expand to all the drugs that have ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride:

Alternative drugs to, pros and cons of Embolex:

Common Embolex side effects:

Browse all side effects of Embolex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Diffuse interstitial lung disease treatments and more:

COVID vaccines that are related to Diffuse interstitial lung disease:

Common drugs associated with Diffuse interstitial lung disease:

All the drugs that are associated with Diffuse interstitial lung disease:

Common conditions associated with Diffuse interstitial lung disease:

All the conditions that are associated with Diffuse interstitial lung disease:

How the study uses the data?

The study uses data from the FDA. It is based on dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride (the active ingredients of Embolex) and Embolex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: